Nuzenio

Marketbeat Sionna Therapeutics

Marketbeat Sionna Therapeutics entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 9 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Timeline

Tue, 11 Aug 2026 04:12:34 GMTSionna Halts SION-719 After Phase 2a Miss, Eyes SION-451 Combination Path - MarketBeat
Tue, 11 Aug 2026 00:46:08 GMTSionna Therapeutics (NASDAQ:SION) Sets New 1-Year Low After Analyst Downgrade - MarketBeat
Mon, 10 Aug 2026 20:13:38 GMTSionna Therapeutics (NASDAQ:SION) Downgraded to "Neutral" Rating by BTIG Research - MarketBeat
Mon, 10 Aug 2026 18:14:23 GMTGuggenheim Reiterates Neutral Rating for Sionna Therapeutics (NASDAQ:SION) - MarketBeat
Mon, 10 Aug 2026 16:10:28 GMTSionna Therapeutics' (SION) "Neutral" Rating Reiterated at Wedbush - MarketBeat
Mon, 10 Aug 2026 16:10:14 GMTSionna Therapeutics (NASDAQ:SION) Upgraded to "Sector Perform" at Royal Bank Of Canada - MarketBeat

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Marketbeat Sionna Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.